Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis

Journal of Infection

Volumn 73, Issue 6, 2016, Pages 547-557

  Flokas, Myrto Eleni ^a   Detsis, Marios ^a   Alevizakos, Michail ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

ESBL; Length of stay; Paediatric; Pediatric; Risk factors; UTI

Indexed keywords

ADOLESCENT; ANTIBIOTIC THERAPY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG USE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; INFANT; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PREVALENCE; REVIEW; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; VESICOURETERAL REFLUX; AFRICA; BIOSYNTHESIS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; EUROPE; INCIDENCE; ISOLATION AND PURIFICATION; META ANALYSIS; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SOUTHEAST ASIA; URINARY TRACT INFECTIONS; WESTERN HEMISPHERE;

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADOLESCENT; AFRICA; AMERICAS; ANTI-BACTERIAL AGENTS; ASIA, SOUTHEASTERN; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EUROPE; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 84995618038     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.07.014     Document Type: Review

References (53)

1. 1 Paterson, D.L., Bonomo, R.A., Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:4 (2005), 657–686.
2. 2 Paterson, D.L., Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 6:9 (2000), 460–463.
3. 3 MacVane, S.H., Tuttle, L.O., Nicolau, D.P., Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med 9:4 (2014), 232–238.
4. 4 Blaschke, A.J., Korgenski, E.K., Daly, J.A., LaFleur, B., Pavia, A.T., Byington, C.L., Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am J Infect Control 37:6 (2009), 435–441.
5. 5 Logan, L.K., Braykov, N.P., Weinstein, R.A., Laxminarayan, R., Extended-spectrum beta-lactamase-producing and third-generation cephalosporin-resistant Enterobacteriaceae in children: trends in the United States, 1999–2011. J Pediatr Infect Dis Soc 3:4 (2014), 320–328.
6. 6 Megged, O., Extended-spectrum beta-lactamase-producing bacteria causing community-acquired urinary tract infections in children. Pediatr Nephrol 29:9 (2014), 1583–1587.
7. 7 Fan, N.C., Chen, H.H., Chen, C.L., Ou, L.S., Lin, T.Y., Tsai, M.H., et al. Rise of community-onset urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect 47:5 (2014), 399–405.
8. 8 Dayan, N., Dabbah, H., Weissman, I., Aga, I., Even, L., Glikman, D., Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr 163:5 (2013), 1417–1421.
9. 9 Park, Y.S., Renal scar formation after urinary tract infection in children. Korean J Pediatr 55:10 (2012), 367–370.
10. 10 van der Meeren, B.T., Chhaganlal, K.D., Pfeiffer, A., Gomez, E., Ferro, J.J., Hilbink, M., et al. Extremely high prevalence of multi-resistance among uropathogens from hospitalised children in Beira, Mozambique. S Afr Med J 103:6 (2013), 382–386.
11. 11 Hanna-Wakim, R.H., Ghanem, S.T., El Helou, M.W., Khafaja, S.A., Shaker, R.A., Hassan, S.A., et al. Epidemiology and characteristics of urinary tract infections in children and adolescents. Front Cell Infect Microbiol, 5, 2015, 45.
12. 12 Robinson, J.L.F.J., Lang, M.E., Bortolussi, R., Urinary tract infection in infants and children: diagnosis and management. Paediatr Child Health 19:6 (2014), 315–319.
13. 13 Roberts, K.B., Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128:3 (2011), 595–610.
14. 14 Centers for Disease Control and Prevention, CDC/NHSN surveillance definitions for specific types of infections. January 2016 [Last accessed 01.04.16]. Available from: http://www.cdc.gov/nhsn/pdfs/pscmanual/2psc_identifyinghais_nhsncurrent.pdf.
15. 15 World Health Organization. WHO regional offices. [Last accessed 9 April 2016]. Available from: http://www.who.int/about/regions/en/.
16. 16 Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [Last accessed 10 March 2016]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/nos_manual.pdf.
17. 17 DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7:3 (1986), 177–188.
18. 18 Nyaga, V.N., Arbyn, M., Aerts, M., Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health, 72(1), 2014, 39.
19. 19 Rucker, G., Schwarzer, G., Carpenter, J.R., Schumacher, M., Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol, 8, 2008, 79.
20. 20 Thompson, S.G., Higgins, J.P.T., How should meta-regression analyses be undertaken and interpreted?. Stat Med 21 (2002), 1559–1573.
21. 21 Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315:7109 (1997), 629–634.
22. 22 Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C., Mylonakis, E., Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and meta-analysis. Clin Infect Dis 63:3 (2016), 310–318.
23. 23 Duong, H.P., Mong Hiep, T.T., Hoang, D.T., Janssen, F., Lepage, P., De Mol, P., et al. Practical problems related to the management of febrile urinary tract infection in Vietnamese children. Arch Pediatr 22:8 (2015), 848–852.
24. 24 Bontemps, S., Lagree, M., Dessein, R., Maftei, A., Martinot, A., Dubos, F., Management of urinary tract infections in children. Evaluation of clinical practice. Arch Pediatr 22:1 (2015), 24–31.
25. 25 Velez Echeverri, C., Serna-Higuita, L.M., Serrano, A.K., Ochoa-Garcia, C., Rojas Rosas, L., Maria Bedoya, A., et al. Resistance profile for pathogens causing urinary tract infection in a pediatric population, and antibiotic treatment response at a university hospital, 2010–2011. Colomb Med (Cali) 45:1 (2014), 39–44.
26. 26 Wu, C.T., Lee, H.Y., Chen, C.L., Tuan, P.L., Chiu, C.H., High prevalence and antimicrobial resistance of urinary tract infection isolates in febrile young children without localizing signs in Taiwan. J Microbiol Immunol Infect 49:2 (2016), 243–248.
27. 27 Crivaro, V., Bogdanovic, L., Bagattini, M., Iula, V.D., Catania, M., Raimondi, F., et al. Surveillance of healthcare-associated infections in a neonatal intensive care unit in Italy during 2006–2010. BMC Infect Dis, 15, 2015, 152.
28. 28 Gallegos, J., Marquez, S., Morales, K., Pena, A., Etiologic and antibiotic susceptibility profile of the first episode of febrile urinary tract infection. Rev Chil Infectol 30:5 (2013), 474–479.
29. 29 Greenhow, T.L., Hung, Y.Y., Herz, A.M., Losada, E., Pantell, R.H., The changing epidemiology of serious bacterial infections in young infants. Pediatr Infect Dis J 33:6 (2014), 595–599.
30. 30 Hernandez Marco, R., Guillen Olmos, E., Breton-Martinez, J.R., Giner Perez, L., Casado Sanchez, B., Fujkova, J., et al. Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants. Enferm Infecc Microbiol Clin, 2016, 10.1016/j.eimc.2016.01.012 [in press].
31. 31 Kaur, N., Sharma, S., Malhotra, S., Madan, P., Hans, C., Urinary tract infection: aetiology and antimicrobial resistance pattern in infants from a tertiary care hospital in northern India. J Clin Diagn Res 8:10 (2014), Dc01–Dc03.
32. 32 Kocak, M., Buyukkaragoz, B., Celebi Tayfur, A., Calt, K.A., Koksoy, A.Y., Cizmeci, Z., et al. Causative pathogens and antibiotic resistances in children hospitalized for urinary tract infections. Pediatr Int 58:6 (2016), 467–471.
33. 33 Raymond, J., Aujard, Y., Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol 21:4 (2000), 260–263.
34. 34 Sakran, W., Smolkin, V., Odetalla, A., Halevy, R., Koren, A., Community-acquired urinary tract infection in hospitalized children: etiology and antimicrobial resistance. A comparison between first episode and recurrent infection. Clin Pediatr (Phila) 54:5 (2015), 479–483.
35. 35 Sharma, S., Ramanan, P.V., Ramachandran, P., Sekar, U., Risk factors for community-acquired urinary tract infection by extended-spectrum β-lactamase–producing organisms in children. J Pediatr Infect Dis 10:02 (2015), 045–046.
36. 36 Morrissey, I., Hackel, M., Badal, R., Bouchillon, S., Hawser, S., Biedenbach, D., A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals 6:11 (2013), 1335–1346.
37. 37 Bryce, A., Hay, A.D., Lane, I.F., Thornton, H.V., Wootton, M., Costelloe, C., Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ, 352, 2016, i939.
38. 38 Dhillon, R.H.-P., Clark, J., ESBLs: a clear and present danger?. Crit Care Res Pract, 2012, 2012, 11.
39. 39 Pogorzelska, M., Stone, P.W., Larson, E.L., Certification in infection control matters: impact of infection control department characteristics and policies on rates of multidrug-resistant infections. Am J Infect Control 40:2 (2012), 96–101.
40. 40 Hawkey, P.M., The growing burden of antimicrobial resistance. J Antimicrob Chemother 62:Suppl. 1 (2008), i1–i9.
41. 41 Mangiarotti, P., Pizzini, C., Fanos, V., Antibiotic prophylaxis in children with relapsing urinary tract infections: review. J Chemother 12:2 (2000), 115–123.
42. 42 Conway, P.H., Cnaan, A., Zaoutis, T., Henry, B.V., Grundmeier, R.W., Keren, R., Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298:2 (2007), 179–186.
43. 43 Keren, R., Shaikh, N., Pohl, H., Gravens-Mueller, L., Ivanova, A., Zaoutis, L., et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics 136:1 (2015), e13–e21.
44. 44 Mathews, R., Mattoo, T.K., The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux–the RIVUR study outcomes. Adv Chronic Kidney Dis 22:4 (2015), 325–330.
45. 45 Craig, J.C., Simpson, J.M., Williams, G.J., Lowe, A., Reynolds, G.J., McTaggart, S.J., et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361:18 (2009), 1748–1759.
46. 46 Esteve-Palau, E., Solande, G., Sanchez, F., Sorli, L., Montero, M., Guerri, R., et al. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study. J Infect 71:6 (2015), 667–674.
47. 47 Dotis, J., Printza, N., Marneri, A., Gidaris, D., Papachristou, F., Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study. Turk J Pediatr 55:6 (2013), 571–574.
48. 48 Horowitz, I.N., Baorto, E., Cirillo, T., Davis, J., Methicillin-resistant Staphylococcus aureus colonization in a pediatric intensive care unit: risk factors. Am J Infect Control 40:2 (2012), 118–122.
49. 49 Zerr, D.M., Miles-Jay, A., Kronman, M.P., Zhou, C., Adler, A.L., Haaland, W., et al. Previous antibiotic exposure increases risk of infection with extended spectrum beta lactamase- and AmpC-producing Escherichia coli and Klebsiella pneumoniae in pediatric patients. Antimicrob Agents Chemother 60:7 (2016), 4237–4243.
50. 50 Kizilca, O., Siraneci, R., Yilmaz, A., Hatipoglu, N., Ozturk, E., Kiyak, A., et al. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 54:6 (2012), 858–862.
51. 51 Abdel-Hady, H., Hawas, S., El-Daker, M., El-Kady, R., Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J Perinatol 28:10 (2008), 685–690.
52. 52 Kayange, N., Kamugisha, E., Mwizamholya, D.L., Jeremiah, S., Mshana, S.E., Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr, 10, 2010, 39.
53. 53 Cheng, C.H., Tsai, M.H., Huang, Y.C., Su, L.H., Tsau, Y.K., Lin, C.J., et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics 122:6 (2008), 1212–1217.